StemCells Inc. (STEM) Posts Narrower Q1 Loss on Light Revs
StemCells Inc. (Nasdaq: STEM) reported Q1 loss of $0.04, $0.02 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $221 thousand versus the consensus estimate of $240 thousand.